Literature DB >> 20185974

Enhanced absorption through damaged skin: an overview of the in vitro human model.

S Gattu1, H I Maibach.   

Abstract

BACKGROUND/AIM: Quantifying percutaneous absorption of topical drugs as well as those compounds relevant to occupational exposure is important for assessing delivery, efficacy and toxicology. Methods for assessing absorption are established for intact skin; however, what may be equally relevant is how much absorption occurs through damaged skin.
METHODS: The Embase database was accessed online in March 2009 in search of human in vitro studies measuring absorption through damaged or diseased skin.
RESULTS: Few studies have measured absorption through damaged human skin in vitro but those that have demonstrate a modest but clear enhancement in absorption with enhancement favoring hydrophilic molecules.
CONCLUSIONS: Damaged or diseased skin may display a modest increase in absorption compared to intact skin; however, more studies with consistent methods and correlations to in vivo data are needed to fully elucidate how much absorption occurs through damaged skin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185974     DOI: 10.1159/000288163

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  9 in total

1.  Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models.

Authors:  Woan-Ruoh Lee; Shing-Chuan Shen; Calvin T Sung; Pei-Ying Liu; Jia-You Fang
Journal:  Pharm Res       Date:  2018-04-26       Impact factor: 4.200

2.  Skin aging modulates percutaneous drug absorption: the impact of ultraviolet irradiation and ovariectomy.

Authors:  Chi-Feng Hung; Wei-Yu Chen; Ibrahim A Aljuffali; Yin-Ku Lin; Hui-Chi Shih; Jia-You Fang
Journal:  Age (Dordr)       Date:  2015-02-27

3.  New aspects in deriving health-based guidance values for bromate in swimming pool water.

Authors:  C Röhl; M Batke; G Damm; A Freyberger; T Gebel; U Gundert-Remy; J G Hengstler; A Mangerich; A Matthiessen; F Partosch; T Schupp; K M Wollin; H Foth
Journal:  Arch Toxicol       Date:  2022-04-06       Impact factor: 6.168

Review 4.  Vesicular Nanocarriers for Phytocompounds in Wound Care: Preparation and Characterization.

Authors:  Diana Antonia Safta; Cătălina Bogdan; Mirela Liliana Moldovan
Journal:  Pharmaceutics       Date:  2022-05-05       Impact factor: 6.525

5.  Effect of topical berberine in murine cutaneous leishmaniasis lesions.

Authors:  Alba Calvo; Esther Moreno; Irati Aldalur; Carmen Sanmartín; Esther Larrea; Elena González-Peñas; Juan Manuel Irache; Socorro Espuelas
Journal:  J Antimicrob Chemother       Date:  2022-03-31       Impact factor: 5.790

6.  Development and validation of an alternative disturbed skin model by mechanical abrasion to study drug penetration.

Authors:  P Schlupp; M Weber; T Schmidts; K Geiger; F Runkel
Journal:  Results Pharma Sci       Date:  2014-09-06

7.  Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs.

Authors:  Yin-Ku Lin; Sien-Hung Yang; Chin-Chuan Chen; Hsiao-Ching Kao; Jia-You Fang
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

8.  Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution.

Authors:  Manfred Bodenlenz; Christian Dragatin; Lisa Liebenberger; Bernd Tschapeller; Beate Boulgaropoulos; Thomas Augustin; Reingard Raml; Christina Gatschelhofer; Nathalie Wagner; Khaled Benkali; Francois Rony; Thomas Pieber; Frank Sinner
Journal:  Pharm Res       Date:  2016-06-06       Impact factor: 4.200

Review 9.  Modeling an Optimal 3D Skin-on-Chip within Microfluidic Devices for Pharmacological Studies.

Authors:  Estibaliz Fernandez-Carro; Maricke Angenent; Tamara Gracia-Cazaña; Yolanda Gilaberte; Clara Alcaine; Jesús Ciriza
Journal:  Pharmaceutics       Date:  2022-07-06       Impact factor: 6.525

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.